Clinical trial
Phase 3 Study to Evaluate the Efficacy and Safety of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)
NCT07037771 is registered in ClinicalTrials.gov with Arrowhead Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3 Study to Evaluate the Efficacy and Safety of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)
- Lead sponsor
- Arrowhead Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- June 17, 2025
- Completion date
- August 20, 2027
- Enrollment
- 70 (actual)
- Sites
- 43
Conditions
As the registry lists them; a condition with its own page is linked.